SNCA and Parkinson disease: The neuronal α-synuclein disease integrated staging system (NSD-ISS) [191] proposes a new definition of PD and DLB under the common concept of neuronal α-synuclein disease, based on the in vivo detection of pathological neuronal α-synuclein, regardless of any specific clinical features.